Specifically, the mediation effect proportions of APOC3 inhibition on the risk of IBD through Lachnospiraceae FCS020 and IL-2ra were estimated to be 17.26% and 10.91%, respectively. Here, APOC3 is linked to inflammatory bowel disease.